Home/Filings/4/0000950170-24-072078
4//SEC Filing

Treace John T. 4

Accession 0000950170-24-072078

CIK 0001630627other

Filed

Jun 10, 8:00 PM ET

Accepted

Jun 11, 5:30 PM ET

Size

8.5 KB

Accession

0000950170-24-072078

Insider Transaction Report

Form 4
Period: 2024-06-11
Treace John T.
DirectorChief Executive Officer10% Owner
Transactions
  • Purchase

    Common Stock

    2024-06-11$5.88/sh+45,000$264,6006,388,095 total
Holdings
  • Common Stock

    (indirect: By Spouse)
    1,605,000
  • Common Stock

    (indirect: By Trust)
    1,839,063
  • Common Stock

    (indirect: By Trust)
    1,471,250
  • Common Stock

    (indirect: By Trust)
    408,816
Footnotes (4)
  • [F1]The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $5.6800 to $5.9100 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.
  • [F2]Includes 196,464 restricted stock units
  • [F3]The Reporting Person disclaims beneficial ownership of shares held by his wife directly or in trusts for which his wife serves as trustee or co-trustee.
  • [F4]The Reporting Person disclaims beneficial ownership of shares held in trust for which he serves as trustee or co-trustee.

Documents

1 file

Issuer

TREACE MEDICAL CONCEPTS, INC.

CIK 0001630627

Entity typeother

Related Parties

1
  • filerCIK 0001856380

Filing Metadata

Form type
4
Filed
Jun 10, 8:00 PM ET
Accepted
Jun 11, 5:30 PM ET
Size
8.5 KB